Search - tctmd.com

Displaying 761 - 780 of 883

Sort: Relevancy | Date

Presentation TCT 2013

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Joachim Schofer

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

‘Obesity Paradox’ Observed in TAVR Patients

Caitlin E. Cox

October 15, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

El Abordaje Transfemoral No es la Única Opción para la TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Caitlin E. Cox

July 19, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

News Daily News

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Yael L. Maxwell

July 12, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

Advertisement

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

No Long-term Decline in Cognitive Performance After TAVR

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

‘Obesity Paradox’ Observed in TAVR Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Transfemoral Access Not Only Option for TAVR

El Abordaje Transfemoral No es la Única Opción para la TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

European TAVR Usage Tied to Economics, Reimbursement

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content